Soluble interleukin-6 receptor activates the human papillomavirus type 18 long control region in SW756 cervical carcinoma cells in a STAT3-dependent manner

Journal of General Virology

Volumn 82, Issue 10, 2001, Pages 2335-2339

  Smola Hess, S ^a   Sandaradura De Silva, U ^a   Hadaschik, D ^a   Pfister, H J ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; NUCLEAR FACTOR; STAT1 PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE CONSTRUCT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; SOLUBILITY; TRANSCRIPTION REGULATION; UTERINE CERVIX CANCER; VIRUS ACTIVATION; VIRUS INDUCTION; VIRUS INHIBITION; WART VIRUS;

EID: 0034790217     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-82-10-2335     Document Type: Article

References (34)

1. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family
2. CD40 ligand-CD40 interaction induces chemokines in cervical carcinoma cells in synergism with IFN-gamma
3. A novel C/EBP beta-YY1 complex controls the cell-type-specific activity of the human papillomavirus type 18 upstream regulatory region
4. Response to IL-6 of HPV-18 cervical carcinoma cell lines
5. Role of CAAT-enhancer binding protein isoforms in the cytokine regulation of acute-phase plasma protein genes
6. Ciliary neurotrophic factor/leukemia inhibitory factor/interleukin 6/oncostatin M family of cytokines induces tyrosine phosphorylation of a common set of proteins overlapping those induced by other cytokines and growth factors
7. Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-beta 2
8. Recombinant IL-6 activates p42 and p44 mitogen-activated protein kinases in the IL-6 responsive B cell line, AF-10
9. Interleukin-6 (IL-6) functions as an autocrine growth factor in cervical carcinomas in vitro
10. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
11. Loss of IL-6 receptor expression in cervical carcinoma cells inhibits autocrine IL-6 stimulation: Abrogation of constitutive monocyte chemoattractant protein-1 production
12. Molecular cloning and expression of an IL-6 signal transducer, gp130
13. Signaling mechanisms through gp130: A model of the cytokine system
14. Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors
15. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
16. Interleukin-6 in human multiple myeloma
17. NF-IL6 represses early gene expression of human papillomavirus type 16 through binding to the noncoding region
18. Association of transcription factor APRF and protein kinase Jak1 with the interleukin-6 signal transducer gp130
19. Constitutive release of IL6 by human papillomavirus type 16 (HPV16)-harboring keratinocytes: A mechanism augmenting the NK-cell-mediated lysis of HPV-bearing neoplastic cells
20. Contribution of IL-6 to the antiproliferative effect of IL-1 and tumor necrosis factor on tumor cell lines
21. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase
22. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells
23. Interleukin-6-induced tethering of STAT3 to the LAP/C/EBPbeta promoter suggests a new mechanism of transcriptional regulation by STAT3
24. The designer cytokine hyper-interleukin-6 is a potent activator of STAT3-dependent gene transcription in vivo and in vitro
25. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment
26. Cooperative transcriptional activity of Jun and Stat3 beta, a short form of Stat3
27. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells
28. Association and activation of Jak-Tyk kinases by CNTFLIF-OSM-IL-6 beta receptor components
29. Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein
30. Transcriptional regulation of human papillomavirus type 16 LCR by different C/EBPbeta isoforms
31. Gp130 and the interleukin-6 family of cytokines
32. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130
33. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6
34. Stat3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6